0001193125-11-124102 Sample Contracts

AGREEMENT AND PLAN OF MERGER by and between RULES-BASED MEDICINE, INC., MYRIAD GENETICS, INC., MYRIAD RBM, INC. and MARK CHANDLER, Ph.D., AS REPRESENTATIVE APRIL 27, 2011

Merger Agreement • May 3rd, 2011 • Myriad Genetics Inc • In vitro & in vivo diagnostic substances • Delaware

• Contract Type
  Merger Agreement
• Filed
  May 3rd, 2011
• Company
  Myriad Genetics Inc
• Industry
  In vitro & in vivo diagnostic substances
• Jurisdiction
  Delaware

THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is dated as of April 27, 2011 and is made by and between Rules-Based Medicine, Inc., a Delaware corporation (the “Company”), Myriad Genetics, Inc., a Delaware corporation (“Parent”), Myriad RBM, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Subsidiary”), and Mark Chandler, Ph.D., in his capacity as the representative of the Stockholders (in such capacity, the “Representative”).